Retia Medical key facts
- Developer of a medical device designed to improve patient care by providing accurate data on blood flow.
- It has raised $22.0M; the latest was Later Stage VC in Jul 2024.
- Notable investors include Michigan State University, PV Capital Management, BioInc@NYMC, Fresenius Medical Care Ventures, Red Cedar Ventures.
- Status: Privately Held (backing).
- ·Watch Retia Medical: the Monday email on marks, rounds and moves
Retia Medical funding rounds
No funding rounds for Retia Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Retia Medical investors
5 investors are on record for Retia Medical, including Michigan State University, PV Capital Management, BioInc@NYMC and Fresenius Medical Care Ventures.
About Retia Medical
Developer of a medical device designed to improve patient care by providing accurate data on blood flow. The company offers a monitoring device that uses a special algorithm to measure blood flow and helps to make informed decisions, enabling doctors to improve patient care in critical conditions like sepsis and transplants.
- Sector
- Healthcare
- HQ
- White Plains, NY, United States
- Founded
- 2011
- Employees
- 16
- Website
- retiamedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Retia Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.